Lesson plan

Paliroden

Paliroden ( ; developmental code names SR-57667 and SR-57667B) is a drug which was under development for the treatment of Alzheimer's disease and Parkinson's disease but was never marketed. It is taken orally. The exact mechanism of action of the drug does not appear to have been disclosed, but it has been found to stimulate neurogenesis in preclinical research. It was under development by sanofi-aventis. Paliroden reached phase 2 clinical trials for Alzheimer's disease and Parkinson's disease prior to the discontinuation of its development in 2007. It is an analogue and follow-on drug of xaliproden (SR-57746; SR-57746A), which is a serotonin 5-HT 1A receptor agonist and neurogenesis stimulant that reached phase 3 trials for similar indications but also did not complete development.

Back to article

Article summary

Paliroden ( ; developmental code names SR-57667 and SR-57667B) is a drug which was under development for the treatment of Alzheimer's disease and Parkinson's disease but was never marketed. It is taken orally. The exact mechanism of action of the drug does not appear to have been disclosed, but it has been found to stimulate neurogenesis in preclinical research. It was under development by sanofi-aventis. Paliroden reached phase 2 clinical trials for Alzheimer's disease and Parkinson's disease prior to the discontinuation of its development in 2007. It is an analogue and follow-on drug of xaliproden (SR-57746; SR-57746A), which is a serotonin 5-HT 1A receptor agonist and neurogenesis stimulant that reached phase 3 trials for similar indications but also did not complete development.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.